Home
Conditions
Heredodegenerative Disorders, Nervous System

Clinical trial condition

Heredodegenerative Disorders, Nervous System

Explore clinical trials studying Heredodegenerative Disorders, Nervous System. Study availability and eligibility vary by location and protocol.

1,876 public trials 411 recruiting studies

Refine in advanced search Browse all conditions

Heredodegenerative Disorders, Nervous System trial results

Recruiting

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

NCT06880991

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas

NCT04750928

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

NCT07209462

Conditions: Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Southwest Autism Research & Resource Center Phoenix, Arizona, United States

Amnova Clinical Research, LLC Irvine, California, United States

Children's Hospital of Orange County - Pediatric Subspecialty Orange, California, United States

Uc Davis Mind Institute Sacramento, California, United States

View all 15 locations

View Trial Details

Recruiting

A Longitudinal Natural History Study of OPA1-Associated Autosomal-Dominant Optic Atrophy

NCT07729982

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Eye Diseases, +13 more
Locations: Department of Ophthalmology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München Munich, Bavaria, Germany

View Trial Details

Recruiting

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

NCT07486934

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Genetic Diseases, Inborn, +18 more
Locations: UCSD - Altman Clinical and Translational Research Institute La Jolla, California, United States

Rare Disease Research, LLC Atlanta, Georgia, United States

IU Health Neuroscience Center Indianapolis, Indiana, United States

Roy Blunt NextGen Precision Health Institute Columbia, Missouri, United States

View all 21 locations

View Trial Details

Recruiting

Natural History Study of Patients With Neurofibromatosis Type 2

NCT00598351

Conditions: Central Nervous System Diseases, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +38 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

NCT06465810

Conditions: ATTR, ATTR-CM, ATTR-Mixed, +20 more
Locations: Research Site La Jolla, California, United States

Research Site Los Angeles, California, United States

Research Site San Francisco, California, United States

Research Site San Francisco, California, United States

View all 82 locations

View Trial Details

Recruiting

Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)

NCT07725926

Conditions: Anxiety Disorders, Basal Ganglia Diseases, Brain Diseases, +21 more
Locations: University College London Hospitals NHS Foundation Trust London, United Kingdom

University College London Queen Square Institute of Neurology London, United Kingdom

View Trial Details

Recruiting

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

NCT06081348

Conditions: 22Q11 Deletion, 22q11 Deletion Syndrome, ADHD, +59 more
Locations: Alberta Children's Hospital - University of Calgary Calgary, Alberta, Canada

University of Alberta-Glenrose Edmonton, Alberta, Canada

Dalhousie University - IWK Health Centre Halifax, Nova Scotia, Canada

McMaster University Hamilton, Ontario, Canada

View Trial Details

Recruiting

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

NCT06735820

Conditions: Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, +24 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Heredodegenerative Disorders, Nervous System

Heredodegenerative Disorders, Nervous System trial results

Related conditions